Breast cancer

Last updated: 01 November 2019

You can legally access new medicines, even if they are not approved in your country.

Learn more »

Lynparza (olaparib) is the first PARP inhibitor approved to treat breast cancer, and the first medicine ever for metastatic breast cancer who have a “BRCA” gene mutation.

Read more